Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. - Wikidata - awgldk - TriplyDB

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

http://www.wikidata.org/entity/Q34629387

about

Curcumin AntiCancer Studies in Pancreatic Cancer Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia.Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.Therapeutic applications of curcumin for patients with pancreatic cancer.Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.The multifaceted role of curcumin in cancer prevention and treatment.Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcumin Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.Complementary and alternative medicines in prostate cancer: from bench to bedside?Effects and synergy of feed ingredients on canine neoplastic cell proliferation Therapeutic Applications of Curcumin Nanoformulations Improvement of Oral Bioavailability of Curcumin upon Microencapsulation with Methacrylic Copolymers.Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.Curcumin nanomedicine: a road to cancer therapeutics Nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the T cell mediated immune response.Hesperidin Induces Apoptosis by Inhibiting Sp1 and Its Regulatory Protein in MSTO-211H Cells Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases.Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment.Curcumin nanoformulations: a future nanomedicine for cancer.Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.Curcumin and liver disease.Curcumin, inflammation, and chronic diseases: how are they linked?The challenges for cancer chemoprevention.Curcumin Nanotechnologies and Its Anticancer Activity.High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.Curcumin induces autophagy in ACC-MESO-1 cells.Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice.A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study.Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers.The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.Antihepatoma activity of Artocarpus communis is higher in fractions with high artocarpin content.Protective and Restorative Effects of Nutrients and Phytochemicals.Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease.Evidence-based complementary treatment of pancreatic cancer: a review of adjunct therapies including paricalcitol, hydroxychloroquine, intravenous vitamin C, statins, metformin, curcumin, and aspirin Curcumin, Cardiometabolic Health and Dementia

P2860

Q26738714-96195966-C48C-4374-91D7-393D97F73333 Q33764245-C9D33820-1719-4A4B-A12B-BDBB502DB268 Q33896515-20D74E66-7A7C-4990-981F-048F136875F1 Q33948351-770D3601-0869-4C13-A214-C1D89BC159F8 Q34252516-F72CCF3C-2B6D-4C2D-904C-A77BA8651A4A Q34667865-A4C7DDF8-8579-4614-AD83-5E27FED86205 Q35692600-5D2E599B-5389-4AA2-AD5D-A104D4CAC0D1 Q35952640-7600E50D-2862-4339-BDAB-1231A6224F1B Q35955023-8728A4B7-1F88-4725-8693-8BFA8F148D81 Q36023716-99F6D9EE-85B8-457D-86B3-66EB6C836A93 Q36051522-46280DA7-CF68-4357-8AE3-64EE4076B6BE Q36092970-3C053CA3-BA7C-4514-9ABF-882CE951687C Q36232513-B101137A-357D-4703-B5DE-735A9BCD4DF7 Q36244041-FDC904DF-F4F9-45EC-8104-5B07B965953A Q36562132-E1236ED0-6615-47E7-A566-7B3ED31F7D11 Q36807261-38416F43-916D-4F66-932E-FF4B46E5B506 Q36881910-F3A5A7DC-9084-4DB5-AEBA-C08EF9D30912 Q37224560-73EC20EE-0687-4391-B2E5-9AB69FC19943 Q37662418-DF403868-8822-43DF-A5BF-D6DD93ED55C8 Q37668848-D801B50E-A0BF-4D4F-9FC2-4AC8C93BED09 Q37729938-F4D477A9-2C9B-41BA-8E0B-610A39F83F46 Q37940793-B915227D-BA24-4C6D-91CC-B30269E670E1 Q38042744-ADE300A1-CD81-495A-9B2F-0623580B9017 Q38072883-4EAF5797-440F-4BBA-8ADA-4CA021B3A760 Q38501499-BF0DEDD2-4FCD-4F02-A3A9-310A4904880A Q38643625-F63339E7-E511-4D00-A256-11CEEA7771E0 Q38746695-8FD622E2-BA95-40CE-BD1E-BABF78CAB841 Q39138022-B22FE44C-EEFB-4ED1-89FE-2E1EE3FD3A01 Q39385991-C5040505-DA19-4BC6-B9E7-A9D9AC918C02 Q41048948-9ACC7C1C-9CF5-4CCA-88C8-DEA9A2003A30 Q44600268-A0849661-F3B5-4970-9C07-EC6B3BA250B1 Q47191893-2A5C0539-3A7A-4D4F-9E33-D42789354945 Q47770834-A50E8440-8251-4B1F-8C4E-6B1513E3EBCF Q49184030-DDCC521D-EDA9-4270-8705-7432D1F24DA6 Q50668061-9DA58C69-E4CD-453B-869B-883373EB9427 Q51418002-17BFE405-B356-4CA1-85BC-656A4614BB77 Q53821180-75595BD8-A1E4-493C-8645-368E56C4445C Q54963833-AB4F23D5-DDA2-4E50-98CD-7D44513196AF Q57176118-9E044D28-4F2F-4EA4-A1B8-20F8355702F4 Q58699640-E0936388-124A-4ABB-BF0F-6F839981A22E

P2860

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

http://www.wikidata.org/entity/Q34629387

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@ast

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@en

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@nl

type

label

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@ast

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@en

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@nl

prefLabel

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@ast

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@en

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@nl

P1433

Q34629387-FE24BDD4-BB1F-4EB7-A438-DB6281441AA9

P1476

Q34629387-C4F9896D-8052-4FE4-951B-9B41E268A5DF

P2093

Q34629387-3B74C462-1352-4511-8013-14B1CDDA39B8

Q34629387-53AF36B6-C57E-4A97-9653-F3AA2D0E0979

Q34629387-6FDE288C-4DDA-4509-BDF8-65E71F4DEA11

Q34629387-7CC6D7F6-8206-449A-A360-E02EF6EF38DB

Q34629387-948E0BF0-7E56-48ED-A9C2-08AF61A8149B

Q34629387-C930F67B-536E-405A-83EF-6318182C7CBE

Q34629387-E1729645-3936-46C2-96D9-10DB3E92BF4F

Q34629387-E298DBA5-F7CC-4D0C-BDCF-769DA8C5839D

Q34629387-FC7517DD-30E6-45D6-BD8B-14143BD2E7AF

P2860

Q34629387-14433C6F-7DE2-41E0-89A5-04C98432A5E4

Q34629387-241F8408-1DFC-42EC-A025-0F096ED8A4E9

Q34629387-2B63006E-FCDE-4440-BFC2-0CB9E49437D7

Q34629387-2E89CDC9-5F53-42E8-82B3-A3812A07632A

Q34629387-2F02BA36-CC99-4642-A7FB-089DEA90EBC6

Q34629387-30D62065-A8B5-4983-97A2-97D16B84FC05

Q34629387-4CC6015A-73A8-4D47-8455-56D8C3CCE5C4

Q34629387-53F1CE72-B27A-45C8-AC05-3C0CC9F1C199

Q34629387-65A68EC6-91DA-4C29-9BF0-DC59B90F0181

Q34629387-69F3CE03-7C79-482C-8716-5D2F2CFEDDF1

P2888

Q34629387-2EBF5AD0-54A1-4374-88C8-5EE837ECFC75

P304

Q34629387-2331143D-2A09-4123-8C00-6FBBE5374BE2

P31

Q34629387-18356F27-EE31-4212-9F83-710F7027AAE1

P356

Q34629387-3640B7EE-890E-4EA7-9BB6-44242C3A6A64

P433

Q34629387-1A2CC846-844E-4CFB-B13A-0B1A60B6F19E

P478

Q34629387-F339EB07-142C-453D-A377-730ED0EA8B10

P577

Q34629387-A80BDEC0-40E5-4A09-B33F-AFB394C6DF8C

P5875

Q34629387-E849523D-2AFD-4D7C-8E0D-69DB3718A041

P6179

Q34629387-F3ED7B4B-5369-4666-94F2-91A4542E0C3F

P698

Q34629387-4DAB8F7C-60BB-462F-B950-2A724CCA8C40

P921

Q34629387-9080A55B-8FC0-4153-B42C-745532DA61BD

Q34629387-d5e8d0a4-dfa6-48e5-aeb1-880b849099b6

P356

S00280-011-1673-1

P1433

Cancer Chemotherapy and Pharmacology

P1476

Dose-escalation and pharmacoki ...... , in healthy human volunteers.

@en

P2093

Atsushi Imaizumi

http://www.w3.org/2001/XMLSchema#string

Hiroki Sasaki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ishiguro

http://www.w3.org/2001/XMLSchema#string

Kazu Tsujiko

http://www.w3.org/2001/XMLSchema#string

Masashi Kanai

http://www.w3.org/2001/XMLSchema#string

Momo Hashiguchi

http://www.w3.org/2001/XMLSchema#string

Shigemi Matsumoto

http://www.w3.org/2001/XMLSchema#string

Tsutomu Chiba

http://www.w3.org/2001/XMLSchema#string

Yoshihiko Otsuka

http://www.w3.org/2001/XMLSchema#string

P2860

Bioavailability of curcumin: problems and promises

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Dose escalation of a curcuminoid formulation

Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.

Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Molecular understanding and modern application of traditional medicines: triumphs and trials.

P2888

s00280-011-1673-1

P304

65-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-011-1673-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51157393

http://www.w3.org/2001/XMLSchema#string

P6179

1021384108

http://www.w3.org/2001/XMLSchema#string

P698

21603867

http://www.w3.org/2001/XMLSchema#string

P921